Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2025

Mar 4, 2025

32853_dirs_2025-03-04_bccd0e0c-6d59-4387-a78b-b9b718e030e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2025-02-28

Reporting Person: Carey Thomas D. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-28 Common Stock A 56338 $1.065 Acquired 99466 Direct

Footnotes

F1: Represents Restricted Stock Units ("RSUs") that vest as to 25% on the last day of the last month of each fiscal quarter of 2025, subject to the Reporting Person's continued service through the applicable vesting date.

F2: The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $60,000 in cash compensation for certain services as a board member.